Cassava Sciences Inc (NASDAQ: SAVA) Has Great Upside Potential

AMMJ Stock

Cassava Sciences Inc (NASDAQ:SAVA) shares, rose in value, with the stock price up by 2.99% to the previous day’s close as strong demand from buyers drove the stock to $2.76.

Actively observing the price movement in the last trading, the stock closed the session at $2.68. Referring to stock’s 52-week performance, its high was $42.20, and the low was $2.23. On the whole, SAVA has fluctuated by 16.95% over the past month.

With the market capitalization of Cassava Sciences Inc currently standing at about $133.33 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SAVA’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the price of SAVA currently trading nearly 11.40% and 9.14% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.93, while the 7-day volatility ratio is showing 12.07% which for the 30-day chart, stands at 7.51%. Furthermore, Cassava Sciences Inc (SAVA)’s beta value is -1.77, and its average true range (ATR) is 0.24.

A comparison of Cassava Sciences Inc (SAVA) with its peers suggests the former has fared considerably weaker in the market. SAVA showed an intraday change of 2.99% in last session, and over the past year, it shrunk by -88.00%%.

Data on historical trading for Cassava Sciences Inc (NASDAQ:SAVA) indicates that the trading volumes over the past 3 months, they’ve averaged 2.53 million. According to company’s latest data on outstanding shares, there are 48.20 million shares outstanding.

Nearly 13.11% of Cassava Sciences Inc’s shares belong to company insiders and institutional investors own 36.25% of the company’s shares. The stock has risen by 16.95% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SAVA stock heading into the next quarter.

Most Popular